Anzeige
Mehr »
Login
Freitag, 26.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
667 Leser
Artikel bewerten:
(2)

Atos International: UK Ministry of Defence selects Atos to deploy digital transformation of healthcare

Paris, France; London, UK - 14 October 2019 - Atos, a global leader in digital transformation, will provide support to the Ministry of Defence (MOD) in the United Kingdom through a contract worth an estimated total value of £25 million GBP to ensure digital transformation in the delivery of healthcare within the UK's Defence services.

The primary objective of the MOD's CORTISONE Programmeis to deliver a suite of Medical Information Services (Med IS) through the exploitation of Commercial off-the-shelf products.

Through the CORTISONE programme, Atos as a delivery partner under service provider 3D, will execute a sustainable, integrated, cohesive and enduring information capability that will fully and effectively support the delivery of evidence-based medical, dental and healthcare outputs, to achieve the aim of the Defence Medical Services.

Atos will maintain and develop the overall solution architecture, artefacts and component integration, providing technical advice and product evaluation, working closely with the MOD ISS (Information Systems & Services) design throughout the process. It will set up and maintain environments, install and configure Commercial off-the-shelf products, build and evaluate interfaces and support data management.

Philip Chalmers, Senior Vice President, Sales and Marketing, Atos in UK and Ireland said: "By adapting commercial industry standard products to create this suite of Medical Information Services, the CORTISONE programme will provide the Defence Medical Services with an integrated and flexible capability that enables digital transformation in the delivery of healthcare within Defence."

The CORTISONE programme will ensure full integration of procured components, supporting implementation and transition. Training services and materials, alongside service management, will also be offered by Atos.

***

About Atos

Atos is a global leader in digital transformation with over 110,000 employees in 73 countries and annual revenue of over € 11 billion. European number one in Cloud, Cybersecurity and High-Performance Computing, the Group provides end-to-end Orchestrated Hybrid Cloud, Big Data, Business Applications and Digital Workplace solutions. The group is the Worldwide Information Technology Partner for the Olympic & Paralympic Games and operates under the brands Atos, Atos Syntel, and Unify. In the UK & Ireland Atos delivers business technology solutions for some of the country's largest public and private sector organisations. Atos is a SE (Societas Europaea), listed on the CAC40 Paris stock index.

The purpose of Atos is to help design the future of the information technology space. Its expertise and services support the development of knowledge, education as well as multicultural and pluralistic approaches to research that contribute to scientific and technological excellence. Across the world, the group enables its customers, employees and collaborators, and members of societies at large to live, work and develop sustainably and confidently in the information technology space.

Press contacts:

Laura Fau | laura.fau@atos.net| +33 6 73 64 04 18 |@laurajanefau

Attachment

  • PR - UK Ministry of Defence selects Atos to deploy digital transformation of healthcare (https://ml-eu.globenewswire.com/Resource/Download/72c75626-2f50-4d16-8d14-ad9cccc7516d)
Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2019 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.